BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mantovani A, Valenti L. A call to action for fatty liver disease. Liver Int 2021;41:1182-5. [DOI: 10.1111/liv.14907] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mantovani A, Lombardi R, Cattazzo F, Zusi C, Cappelli D, Dalbeni A. MAFLD and CKD: An Updated Narrative Review. IJMS 2022;23:7007. [DOI: 10.3390/ijms23137007] [Reference Citation Analysis]
2 Valenti L, Romeo S, Pajvani U. A genetic hypothesis for burnt-out steatohepatitis. Liver Int 2021;41:2816-8. [PMID: 34935283 DOI: 10.1111/liv.15103] [Reference Citation Analysis]
3 Wang X, Liu X, He P, Guan K, Yang Y, Lei Y, Cai J, Wang W, Wu T, Rauf A. The Imbalance of Mitochondrial Homeostasis of Peripheral Blood-Derived Macrophages Mediated by MAFLD May Impair the Walking Ability of Elderly Patients with Osteopenia. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/5210870] [Reference Citation Analysis]
4 Panteghini M. The new multidisciplinary paradigm for fatty liver disease should also include the laboratory medicine contribution. Liver Int 2021;41:1981-2. [PMID: 34152694 DOI: 10.1111/liv.14987] [Reference Citation Analysis]
5 Mantovani A, Dalbeni A, Beatrice G, Cappelli D, Gomez-peralta F. Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes. JCM 2022;11:968. [DOI: 10.3390/jcm11040968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]